Xu Xing Lu
Directeur/Membre du Conseil chez Zhejiang Test Bio-Tech Co. Ltd.
Profil
Xu Xing Lu is currently an Executive Director at Zhejiang Test Bio-Tech Co. Ltd.
and a Director at Shanghai Xingaofeng Biological Medicine Co., Ltd.
Previously, Mr. Lu worked as the Vice Chairman & General Manager at Zhejiang Yatai Pharmaceutical Co., Ltd.
from 2013 to 2017 and as a Director at Shanghai Newsummit Biopharma Group Co., Ltd.
Postes actifs de Xu Xing Lu
| Sociétés | Poste | Début |
|---|---|---|
Zhejiang Test Bio-Tech Co. Ltd.
 Zhejiang Test Bio-Tech Co. Ltd. Medical SpecialtiesHealth Technology Zhejiang Test Bio-Tech Co. Ltd. manufactures and distributes in vitro diagnostic reagents. It engages in clinical biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and other new type of in vitro diagnostic reagents R&D, production and sales service. The company was founded in 2011 and is headquartered in Shaoxing, China. | Directeur/Membre du Conseil | - |
Shanghai Xingaofeng Biological Medicine Co., Ltd.
 Shanghai Xingaofeng Biological Medicine Co., Ltd. BiotechnologyHealth Technology Part of Zhejiang Yatai Pharmaceutical Co., Ltd., Shanghai Xingaofeng Biological Medicine Co., Ltd. is a biotechnology company based in Shanghai, CN. Shanghai Xingaofeng Biological Medicine Co. was acquired by Zhejiang Yatai Pharmaceutical Co., Ltd. from Green Villa Holdings Ltd. on December 02, 2015 for $141.84 million. The Chinese company engages in the development of biotechnology. The company was founded in 2007. The CEO is Li Yun Wang. | Directeur/Membre du Conseil | - |
Anciens postes connus de Xu Xing Lu
| Sociétés | Poste | Fin |
|---|---|---|
| ZHEJIANG YATAI PHARMACEUTICAL CO., LTD. | Directeur Général | 16/05/2017 |
Shanghai Newsummit Biopharma Group Co., Ltd.
 Shanghai Newsummit Biopharma Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Newsummit Biopharma Group Co., Ltd. provides new drug development process solutions. Its services include pre-clinical development, clinical development, and assistance in the preparation of the regulatory submission of investigational new drug and new drug applications. The company also involves in the provision of technical services for medical devices research. Shanghai Newsummit Biopharma Group was founded by Jun Ren in 2001 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZHEJIANG YATAI PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Zhejiang Test Bio-Tech Co. Ltd.
Zhejiang Test Bio-Tech Co. Ltd. Medical SpecialtiesHealth Technology Zhejiang Test Bio-Tech Co. Ltd. manufactures and distributes in vitro diagnostic reagents. It engages in clinical biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and other new type of in vitro diagnostic reagents R&D, production and sales service. The company was founded in 2011 and is headquartered in Shaoxing, China. | Health Technology |
Shanghai Newsummit Biopharma Group Co., Ltd.
Shanghai Newsummit Biopharma Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Newsummit Biopharma Group Co., Ltd. provides new drug development process solutions. Its services include pre-clinical development, clinical development, and assistance in the preparation of the regulatory submission of investigational new drug and new drug applications. The company also involves in the provision of technical services for medical devices research. Shanghai Newsummit Biopharma Group was founded by Jun Ren in 2001 and is headquartered in Shanghai, China. | Commercial Services |
Shanghai Xingaofeng Biological Medicine Co., Ltd.
Shanghai Xingaofeng Biological Medicine Co., Ltd. BiotechnologyHealth Technology Part of Zhejiang Yatai Pharmaceutical Co., Ltd., Shanghai Xingaofeng Biological Medicine Co., Ltd. is a biotechnology company based in Shanghai, CN. Shanghai Xingaofeng Biological Medicine Co. was acquired by Zhejiang Yatai Pharmaceutical Co., Ltd. from Green Villa Holdings Ltd. on December 02, 2015 for $141.84 million. The Chinese company engages in the development of biotechnology. The company was founded in 2007. The CEO is Li Yun Wang. | Health Technology |
